CDKN2A and astrocytoma (excluding glioblastoma): In addition, 3 samples with astrocytoma, IDH-mutant (WHO grade II: 1; WHO grade III: 2) were graded as CNS WHO grade 4 as they harbored homozygous deletions of CDKN2A/B (all LTS).